ARID1A loss leads to chemotherapy resistance and is associated with a poor clinic outcome for patients with non-small cell lung cancer

被引：1
|
作者：
Yang, Linlin [1 ]
Shen, Changxian [1 ]
Mo, Xiaokui [2 ]
Williams, Terence M. [1 ]
机构：
[1] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-4155
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4155
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] Loss of ARID1A expression is associated with poor prognosis in non-small cell lung cancer
    Jang, Si-Hyong
    Lee, Ji-Hye
    Lee, Hyun Ju
    Cho, Hyundeuk
    Ahn, Hyein
    Song, In Hag
    Oh, Mee-Hye
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (11)
  • [2] Downregulation of ARID1A is correlated with poor prognosis in non-small cell lung cancer
    Wang, Tao
    Guo, Jinyan
    Liu, Wenhua
    Guo, Qi
    Cheng, Lvhuan
    Zheng, Renshan
    Hu, Xinchun
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (08) : 4896 - 4905
  • [3] Demographic and Genomic Characteristics of Non-Small Cell Lung Cancer Patients with ARID1A Alterations
    Al-Obeidi, E.
    Williams, A.
    Burkert, N.
    Pepin, K.
    Hicks, J. K.
    Gray, J. E.
    Stewart, S.
    Weipert, C.
    Waqar, S.
    Spigel, D.
    Salgia, R.
    Massarelli, E.
    Baik, C. S.
    Neal, J. W.
    Ramchandran, K.
    Xia, B.
    Carpenter, E. L.
    Aggarwal, C.
    Riess, J. W.
    Gandara, D.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S489 - S489
  • [4] ARID1A is downregulated in non-small cell lung cancer and regulates cell proliferation and apoptosis
    Zhang, Yi
    Xu, Xiaoman
    Zhang, Meng
    Bai, Xue
    Li, Hui
    Kan, Liang
    Niu, Huiyan
    He, Ping
    TUMOR BIOLOGY, 2014, 35 (06) : 5701 - 5707
  • [5] ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer
    Dantong Sun
    Fei Teng
    Puyuan Xing
    Junling Li
    Molecular Medicine, 2021, 27
  • [6] ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer
    Sun, Dantong
    Teng, Fei
    Xing, Puyuan
    Li, Junling
    MOLECULAR MEDICINE, 2021, 27 (01)
  • [7] CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer
    Si, Jiahui
    Zhang, Panpan
    Tian, Dan
    Wang, Xing
    Ma, Yuanyuan
    Zhang, Jianzhi
    Wang, Lu
    Yang, Yue
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15
  • [8] CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer
    Jiahui Si
    Panpan Zhang
    Dan Tian
    Xing Wang
    Yuanyuan Ma
    Jianzhi Zhang
    Lu Wang
    Yue Yang
    World Journal of Surgical Oncology, 15
  • [9] Prevalence and Clinicopathological Characteristics of ARID1A Mutations in East Asian Patients With Non-Small Cell Lung Cancer
    Xu, C.
    Wang, W.
    Wang, D.
    Zhu, Y.
    Zhuang, W.
    Fang, M.
    Wang, G.
    Wang, Q.
    Song, Y.
    Lu, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1214 - S1215
  • [10] Loss of ARID1A expression is associated with poor prognosis in patients with gastric cancer
    Zhu, Yi Ping
    Sheng, Li Li
    Wu, Jing
    Yang, Mo
    Chen, Xian Feng
    Wu, Ning Ni
    Ye, Xiao Bing
    Cai, Juan
    Wang, Lu
    Shen, Qian
    Wu, Jian Qiu
    HUMAN PATHOLOGY, 2018, 78 : 28 - 35
12345